Drug-loaded Prussian blue and manganese fibrin composite gel, and preparation method and application thereof

A Prussian blue and composite gel technology, applied in the field of drug-loaded Prussian blue@manganese fibrin composite gel and preparation, can solve the problems of multidrug resistance, high toxicity, low bioavailability, etc. The effect of improving stability and simple preparation method

Active Publication Date: 2021-12-24
ZHENGZHOU UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The purpose of the present invention is to overcome the deficiencies of the existing preparations, and provide drug-loaded Prussian blue@manganese fibrin composite gel and its preparation method and application. It activates immune pathways, realizes the therapeutic effect of sonodynamics-immunity synergy, and also promotes the repair and healing of wounds, thereby solving the problems of low bioavailability, high toxicity, and multidrug resistance in current treatments.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug-loaded Prussian blue and manganese fibrin composite gel, and preparation method and application thereof
  • Drug-loaded Prussian blue and manganese fibrin composite gel, and preparation method and application thereof
  • Drug-loaded Prussian blue and manganese fibrin composite gel, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] A drug-loaded Prussian blue@manganese fibrin composite gel, in which mesoporous Prussian blue nanoparticles are etched to form hollow Prussian blue, and manganese is coated on the outer surface and internal mesoporous channels of the hollow Prussian blue nanoparticles The ions form hollow Prussian blue@manganese nanoparticles, and the hollow Prussian blue@manganese nanoparticles are targeted modified, hole-loaded sonosensitizer chlorin and coated oligomeric hyaluronic acid to obtain coated oligomeric hyaluronic acid The hollow Prussian blue@manganese nanoparticles of acid were mixed with the fibrinogen solution containing the hollow Prussian blue@manganese nanoparticles coated with oligomeric hyaluronic acid under the stimulation of thrombin to form a composite gel. The diameter is 120nm.

[0044] The preparation method of the above drug-loaded Prussian blue@manganese fibrin composite gel comprises the following steps:

[0045] Step 1, take by weighing the potassium fe...

Embodiment 2

[0058] A drug-loaded Prussian blue@manganese fibrin composite gel, which forms hollow Prussian blue by etching mesoporous Prussian blue nanoparticles, and coats the outer surface and internal mesoporous channels of the hollow Prussian blue nanoparticles Manganese ions are added to form empty Prussian blue@manganese nanoparticles, and the hollow Prussian blue@manganese nanoparticles are targeted modified, the hole is loaded with the sonosensitizer chlorin, and the coated oligomeric hyaluronic acid is obtained to obtain the coated oligomeric The hollow Prussian blue@manganese nanoparticles of hyaluronic acid are mixed with the fibrinogen solution containing the hollow Prussian blue@manganese nanoparticles coated with oligomeric hyaluronic acid under the stimulation of thrombin to form a composite gel. The particle size is 100nm.

[0059] The preparation method of the above drug-loaded Prussian blue@manganese fibrin composite gel comprises the following steps:

[0060] Step 1. W...

Embodiment 3

[0068] A drug-loaded Prussian blue@manganese fibrin composite gel, which etches mesoporous Prussian blue nanoparticles to form hollow Prussian blue, and coats the outer surface and internal mesoporous channels of the hollow Prussian blue nanoparticles Manganese ions form empty Prussian blue@manganese nanoparticles, and the hollow Prussian blue@manganese nanoparticles are targeted modified, hole-loaded sonosensitizer chlorin and coated oligomeric hyaluronic acid to obtain coated oligomeric transparent The hollow Prussian blue@manganese nanoparticles of hyaluronic acid are mixed with the fibrinogen solution containing the hollow Prussian blue@manganese nanoparticles coated with oligomeric hyaluronic acid under the stimulation of thrombin to form a composite gel. The diameter is 60nm.

[0069] The preparation method of the above drug-loaded Prussian blue@manganese fibrin composite gel comprises the following steps:

[0070] Step 1. Weigh 5g of PVP-K30 powder and 50mM K 3 [Fe(CN...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention belongs to the field of biological medicine, and provides drug-loaded Prussian blue and manganese fibrin composite gel, and a preparation method and application thereof. Mesoporous Prussian blue nanoparticles are etched to form hollow Prussian blue nanoparticles; the hollow Prussian blue nanoparticles are coated with manganese ions to form hollow Prussian blue and manganese nanoparticles; the hollow Prussian blue and manganese nanoparticles are subjected totargeted modification; holes of the hollow Prussian blue and manganese nanoparticles are loaded with a sound-sensitive agent and coated with oligomeric hyaluronic acid; and finally, it is mixed with a fibrinogen solution under the stimulation of thrombin to form the composite gel. According to the invention, the novel sound-sensitive agent is loaded in the holes of the hollow Prussian blue nanoparticles; the oligomeric hyaluronic acid is modified on the outer surface, so that the targeting effect can be achieved, and the immunosuppressive microenvironment of tumors can be adjusted; and the composite gel not only can realize the enhanced sonodynamic-immune synergistic treatment effect on postoperative residual tumor tissues, but also can accelerate the repair and healing of postoperative wounds.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a drug-loaded Prussian blue@manganese fibrin composite gel, a preparation method and an application thereof. Background technique [0002] Cancer is one of the major diseases that endanger human health. Clinically, the main strategies for the treatment of cancer can be divided into: surgery, radiotherapy, chemotherapy and biological therapy. Surgical treatment is still the most important method in clinical treatment, but the high recurrence rate of cancer after surgery is still an urgent problem to be solved. Sonodynamic therapy (SDT) is a new anti-tumor treatment method established and developed on the basis of photodynamic therapy. The function of SDT is based on the synergistic effect of three substances: sound sensitizer, ultrasonic wave and oxygen. SDT mainly uses ultrasound to penetrate deep into the tissue, activate sound-sensitizers such as porphyrin and its deri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K41/00A61K33/32A61K33/26A61K9/06A61K47/42A61K47/36A61K47/02A61P35/00A61P17/02B82Y5/00B82Y30/00B82Y40/00
CPCA61K41/0033A61K33/32A61K33/26A61K9/06A61K47/42A61K47/36A61K47/02A61P35/00A61P17/02B82Y5/00B82Y30/00B82Y40/00A61K2300/00
Inventor 胡玉荣周晨阳马紫君赵腾月李春明宋成治杨烨菲饶志伟
Owner ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products